top of page
Lead: RSV Vaccine
Follow On: Universal Flu Vaccine
Use tab to navigate through the menu items.
Leadership Team Comprises Expertise Necessary to Develop Products & Company
Christopher Marshall, Ph.D. Founder and Chief Executive Officer
PhD, The Rockefeller University. Expert in virology & protein science. Founded three Biotechs.
Mark A. Yondola, Ph.D., Founder and Chief Science Officer
PhD, Stony Brook University; Post-doctoral Fellowship, Mt. Sinai. Vaccine design, protein chemistry & virology expert.
Dirk Pleimes, M.D., Chief Medical Officer
Founded 4 biotechs. Expert in pharmaceutical clinical development & respiratory-inflammatory disease.
Sonal Gidwani, MS, Principal Scientist
Expert in crosslinking chemistry and controls; analytical development.
Devarshi Brahmbhatt, M.S., Principal Scientist
Expert in downstream process design, development, and protein chemistry.
Barry Buckland, Ph.D., SAB
CEO, BioLogicB. Former Merck Vaccines, VP Manufacturing for 16 years. Manufactured a large number of approved vaccine products.
Florian Schödel, M.D., SAB
Merck Vaccines, VP Clinical Research for 8 years. Directed clinical studies for licensure of multiple approved vaccines.
Jason S. McLellan, Ph.D., SAB
Univ. of Texas. Pre-eminent in vaccine design. Many Covid-19 vaccines programs based on Dr. McLellan's 2P-design.
Alexander Hoffmann, Ph.D., SAB
UCLA. Pre-eminent in the field of innate immunity (adjuvants); Director, Instit. for Quant. & Computational Biosciences.
James E. Hough, JD, EIR
Expert in Residence. Consulting on communications and strategy; partner at Morrison & Foerster LLP for 25+ years
Peter Alff, EIR
Expert in Residence. Advising on corporate development strategies. Biotech VC, former Head of Strategic Initiatives
Claudio Bertuccioli, Ph.D., EIR
Expert in Residence. Advising on financing strategies. Biotech VC for 15 years.
bottom of page